Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Pulmatrix Revenue 2014-2019 | PULM

Pulmatrix revenue from 2014 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Pulmatrix Annual Revenue
(Millions of US $)
2018 $0
2017 $0
2016 $1
2015 $1
2014 $0
2014 $0
2013 $0
2013 $0
2012 $0
Pulmatrix Quarterly Revenue
(Millions of US $)
Q1 2019 $0
Q4 2018 $0
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $1
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.018B $0.000B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $111.478B 12.60
Gilead Sciences (GILD) United States $87.024B 10.57
Celgene (CELG) United States $68.996B 11.69
Illumina (ILMN) United States $51.735B 59.96
Vertex Pharmaceuticals (VRTX) United States $46.550B 56.27
Biogen (BIIB) United States $45.350B 8.61
Regeneron Pharmaceuticals (REGN) United States $33.966B 15.97
Alexion Pharmaceuticals (ALXN) United States $27.754B 15.71
Incyte (INCY) United States $18.199B 73.80
BioMarin Pharmaceutical (BMRN) United States $15.225B 0.00
Exact Sciences (EXAS) United States $14.979B 0.00
Seattle Genetics (SGEN) United States $11.676B 0.00
Array BioPharma (ARRY) United States $10.311B 0.00
Sarepta Therapeutics (SRPT) United States $9.967B 0.00
QIAGEN (QGEN) Netherlands $9.171B 30.13
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.996B 54.56
Guardant Health (GH) United States $7.795B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.667B 0.00
Bluebird Bio (BLUE) United States $6.597B 0.00
Galapagos (GLPG) Belgium $6.461B 0.00
Amarin (AMRN) Ireland $6.422B 0.00
Exelixis (EXEL) United States $6.328B 16.13
BeiGene (BGNE) Cayman Islands $5.593B 0.00
Ascendis Pharma (ASND) Denmark $5.315B 0.00
Moderna (MRNA) United States $5.100B 0.00
Blueprint Medicines (BPMC) United States $4.728B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.415B 0.00
Spark Therapeutics (ONCE) United States $3.965B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.838B 0.00
Repligen (RGEN) United States $3.830B 95.41
China Biologic Products (CBPO) China $3.715B 23.60
Mirati Therapeutics (MRTX) United States $3.649B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.636B 0.00
Alkermes (ALKS) Ireland $3.504B 0.00
Allogene Therapeutics (ALLO) United States $3.415B 0.00
Global Blood Therapeutics (GBT) United States $3.303B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.167B 0.00
UniQure (QURE) Netherlands $2.927B 0.00
Arena Pharmaceuticals (ARNA) United States $2.870B 5.83
Amicus Therapeutics (FOLD) United States $2.855B 0.00
Lion Biotechnologies (IOVA) United States $2.764B 0.00
Medicines (MDCO) United States $2.603B 0.00
Reata Pharmaceuticals (RETA) United States $2.554B 0.00
Immunomedics (IMMU) United States $2.536B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.484B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.480B 0.00
Halozyme Therapeutics (HALO) United States $2.420B 0.00
Emergent Biosolutions (EBS) United States $2.392B 20.77
NeoGenomics (NEO) United States $2.287B 149.69
Ligand Pharmaceuticals (LGND) United States $2.247B 18.61
MyoKardia (MYOK) United States $2.214B 0.00
Akcea Therapeutics (AKCA) United States $2.115B 0.00
Acceleron Pharma (XLRN) United States $2.103B 0.00
Insmed (INSM) United States $2.021B 0.00
Genomic Health (GHDX) United States $2.011B 42.72
REGENXBIO (RGNX) United States $1.903B 0.00
Allakos (ALLK) United States $1.903B 0.00
Denali Therapeutics (DNLI) United States $1.902B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.873B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.810B 0.00
AnaptysBio (ANAB) United States $1.799B 0.00
Myriad Genetics (MYGN) United States $1.780B 17.71
Audentes Therapeutics (BOLD) United States $1.772B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.533B 0.00
Apellis Pharmaceuticals (APLS) United States $1.506B 0.00
Gossamer Bio (GOSS) United States $1.471B 0.00
Cambrex (CBM) United States $1.461B 18.48
Innoviva (INVA) United States $1.457B 4.03
Coherus BioSciences (CHRS) United States $1.433B 0.00
Alector (ALEC) United States $1.317B 0.00
Fate Therapeutics (FATE) United States $1.303B 0.00
Aimmune Therapeutics (AIMT) United States $1.254B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.246B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.242B 0.00
Athenex (ATNX) United States $1.207B 0.00
Epizyme (EPZM) United States $1.204B 0.00
Eidos Therapeutics (EIDX) United States $1.139B 0.00
Sangamo Therapeutics (SGMO) United States $1.120B 0.00
Editas Medicine (EDIT) United States $1.117B 0.00
Rubius Therapeutics (RUBY) United States $1.102B 0.00
CORTEXYME INC (CRTX) United States $1.100B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.052B 0.00
Codexis (CDXS) United States $1.022B 0.00
RA PHARMCTL INC (RARX) United States $1.011B 0.00
Atara Biotherapeutics (ATRA) United States $1.011B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $1.006B 0.00
G1 THERAPEUTICS (GTHX) United States $0.984B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.964B 0.00
Twist Bioscience (TWST) United States $0.950B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.934B 0.00
WAVE Life Sciences (WVE) Singapore $0.923B 0.00
NGM Biopharmaceuticals (NGM) United States $0.908B 0.00
ANI Pharmaceuticals (ANIP) United States $0.896B 15.90
Inotek Pharmaceuticals (RCKT) United States $0.859B 0.00
Principia Biopharma (PRNB) United States $0.849B 0.00
Retrophin (RTRX) United States $0.831B 0.00
Axsome Therapeutics (AXSM) United States $0.825B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.790B 0.00
Cara Therapeutics (CARA) United States $0.784B 0.00
Clovis Oncology (CLVS) United States $0.783B 0.00
Intra-Cellular Therapies (ITCI) United States $0.777B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.774B 36.53
GENFIT Unsponsored ADR (GNFT) France $0.774B 0.00
Vericel (VCEL) United States $0.766B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.756B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.756B 0.00
Adverum Biotechnologies (ADVM) United States $0.733B 0.00
Arvinas (ARVN) United States $0.722B 0.00
MeiraGTx Holdings (MGTX) United States $0.710B 0.00
Kura Oncology (KURA) United States $0.705B 0.00
Precision BioSciences (DTIL) United States $0.698B 0.00
Stemline Therapeutics (STML) United States $0.683B 0.00
Intellia Therapeutics (NTLA) United States $0.677B 0.00
Myovant Sciences (MYOV) United Kingdom $0.674B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.668B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.664B 0.00
Zealand Pharma (ZEAL) Denmark $0.645B 7.54
Heska (HSKA) United States $0.643B 65.88
Cytokineticsorporated (CYTK) United States $0.643B 0.00
Cellectis (CLLS) France $0.619B 0.00
Viking Therapeutics (VKTX) United States $0.593B 0.00
Zymeworks (ZYME) Canada $0.587B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.573B 0.00
Anika Therapeutics (ANIK) United States $0.568B 19.42
Puma Biotechnology (PBYI) United States $0.543B 0.00
BeyondSpring (BYSI) United States $0.519B 0.00
CytomX Therapeutics (CTMX) United States $0.512B 0.00
Revance Therapeutics (RVNC) United States $0.509B 0.00
DBV Technologies (DBVT) France $0.509B 0.00
ObsEva SA (OBSV) Switzerland $0.490B 0.00
Magenta Therapeutics (MGTA) United States $0.489B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Sorrento Therapeutics (SRNE) United States $0.450B 0.00
Scholar Rock Holding (SRRK) United States $0.449B 0.00
Mesoblast (MESO) Australia $0.447B 0.00
Kodiak Sciences (KOD) United States $0.441B 0.00
Synthorx (THOR) United States $0.432B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.424B 0.00
BioDelivery Sciences (BDSI) United States $0.417B 0.00
Krystal Biotech (KRYS) United States $0.417B 0.00
MediciNova (MNOV) United States $0.416B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.415B 0.00
Arcus Biosciences (RCUS) United States $0.413B 0.00
Provention Bio (PRVB) United States $0.411B 0.00
Replimune (REPL) United States $0.411B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
Agenus (AGEN) United States $0.396B 0.00
AC Immune SA (ACIU) Switzerland $0.391B 25.17
Kaleido Biosciences (KLDO) $0.389B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.389B 0.00
Gritstone Oncology (GRTS) United States $0.388B 0.00
UNITY Biotechnology (UBX) $0.386B 0.00
Albireo Pharma (ALBO) United States $0.385B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.382B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
ResTORbio (TORC) United States $0.365B 0.00
Acorda Therapeutics (ACOR) United States $0.363B 6.39
Adaptimmune Therapeutics (ADAP) United Kingdom $0.362B 0.00
PDL BioPharma (PDLI) United States $0.361B 8.63
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.356B 0.00
AVROBIO (AVRO) United States $0.353B 0.00
Merus (MRUS) Netherlands $0.344B 0.00
NEXTCURE INC (NXTC) United States $0.338B 0.00
Senesco Technologies (ELOX) United States $0.337B 0.00
LogicBio Therapeutics (LOGC) United States $0.335B 0.00
Kindred Biosciences (KIN) United States $0.325B 0.00
Cyclerion Therapeutics (CYCN) United States $0.314B 0.00
PHASEBIO PHARMA (PHAS) United States $0.299B 0.00
Geron (GERN) United States $0.297B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.296B 0.00
Syros Pharmaceuticals (SYRS) United States $0.293B 0.00
Protagonist Therapeutics (PTGX) United States $0.282B 0.00
Evelo Biosciences (EVLO) United States $0.281B 0.00
Athersys (ATHX) United States $0.273B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Cellular Biomedicine (CBMG) United States $0.271B 0.00
XBiotech (XBIT) United States $0.267B 0.00
Palatin Technologies (PTN) United States $0.266B 0.00
Constellation Pharmaceuticals (CNST) United States $0.265B 0.00
Dynavax Technologies (DVAX) United States $0.259B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.257B 0.00
Chiasma (CHMA) United States $0.254B 0.00
Urovant Sciences (UROV) United States $0.248B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Abeona Therapeutics (ABEO) United States $0.240B 0.00
Synlogic (SYBX) United States $0.238B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.237B 0.00
Five Prime Therapeutics (FPRX) United States $0.235B 0.00
Neothetics (EVFM) United States $0.233B 0.00
Kadmon Holdings (KDMN) United States $0.233B 0.00
AXCELLA HEALTH (AXLA) United States $0.232B 0.00
ChromaDex (CDXC) United States $0.227B 0.00
Celcuity (CELC) United States $0.226B 0.00
Spero Therapeutics (SPRO) United States $0.225B 0.00
Kamada (KMDA) Israel $0.224B 8.69
MannKind (MNKD) United States $0.223B 0.00
Cel-Sci (CVM) United States $0.222B 0.00
Avid Bioservices (CDMO) United States $0.219B 0.00
Pfenex (PFNX) United States $0.218B 0.00
Cerecor (CERC) United States $0.216B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.211B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.211B 0.00
IDEAYA BIOSCI (IDYA) United States $0.209B 0.00
ADMA Biologics Inc (ADMA) United States $0.209B 0.00
Affimed (AFMD) Germany $0.209B 0.00
Enochian BioSciences (ENOB) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.197B 0.00
Mersana Therapeutics (MRSN) United States $0.197B 0.00
Enzo Biochem (ENZ) United States $0.192B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.188B 0.00
Arsanis (XFOR) United States $0.186B 0.00
Dyadic (DYAI) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.185B 10.69
Compugen (CGEN) Israel $0.184B 0.00
Solid Biosciences (SLDB) United States $0.184B 0.00
CorMedix Inc (CRMD) United States $0.181B 0.00
Gamida Cell (GMDA) Israel $0.179B 0.00
BioXcel Therapeutics (BTAI) United States $0.174B 0.00
OSMOTICA PHARM (OSMT) United States $0.170B 0.00
TREVI THERAPTCS (TRVI) United States $0.169B 0.00
HOOKIPA PHARMA (HOOK) United States $0.168B 0.00
BioTime (BTX) United States $0.166B 11.10
Anavex Life Sciences (AVXL) United States $0.164B 0.00
Liquidia Technologies (LQDA) United States $0.163B 0.00
XOMA (XOMA) United States $0.161B 0.00
OvaScience (MLND) United States $0.161B 0.00
APPLIED THERAPT (APLT) United States $0.158B 0.00
Menlo Therapeutics (MNLO) United States $0.156B 0.00
Kezar Life Sciences (KZR) United States $0.156B 0.00
Aduro Biotech (ADRO) United States $0.153B 0.00
TOCAGEN INC (TOCA) United States $0.152B 0.00
Cue Biopharma (CUE) United States $0.149B 0.00
Checkpoint Therapeutics (CKPT) United States $0.149B 0.00
Mustang Bio (MBIO) United States $0.146B 0.00
Verastem (VSTM) United States $0.140B 0.00
Intec Pharma (NTEC) Israel $0.137B 0.00
Eton Pharmaceuticals (ETON) United States $0.130B 0.00
Axovant Sciences (AXGT) United States $0.127B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.124B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.123B 0.00
Novavax (NVAX) United States $0.121B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
Celyad SA (CYAD) Belgium $0.119B 0.00
Fortress Biotech (FBIO) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Aptose Biosciences (APTO) Canada $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
NantKwest (NK) United States $0.113B 0.00
VolitionRX (VNRX) Singapore $0.112B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.112B 0.00
Seres Therapeutics (MCRB) United States $0.108B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.106B 0.00
Equillium (EQ) United States $0.104B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Trevena (TRVN) United States $0.104B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.099B 0.00
Arbutus Biopharma (ABUS) Canada $0.098B 0.00
Allena Pharmaceuticals (ALNA) United States $0.096B 0.00
Selecta Biosciences (SELB) United States $0.092B 0.00
Catalyst Biosciences (CBIO) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
Alcobra (ARCT) United States $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.079B 0.00
VBI Vaccines (VBIV) United States $0.077B 0.00
Unum Therapeutics (UMRX) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
Cohbar (CWBR) United States $0.074B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Signal Genetics (MGEN) United States $0.073B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Spring Bank Pharmaceuticals (SBPH) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
OVID THERAPEUTC (OVID) United States $0.069B 0.00
Cocrystal Pharma (COCP) United States $0.068B 72.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Orgenesis (ORGS) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Hoth Therapeutics (HOTH) United States $0.058B 0.00
Moleculin Biotech (MBRX) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Zosano Pharma (ZSAN) United States $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Ophthotech (ISEE) United States $0.054B 0.00
Curis (CRIS) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
AEterna Zentaris (AEZS) United States $0.048B 0.00
DiaMedica Therapeutics (DMAC) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
Cidara Therapeutics (CDTX) United States $0.044B 0.00
Entera Bio (ENTX) Israel $0.044B 0.00
Aptevo Therapeutics (APVO) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
VIVUS (VVUS) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.033B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Bison Capital Acquisition (XYN) China $0.027B 0.00
Sophiris Bio (SPHS) United States $0.026B 0.00
GTx (ONCT) United States $0.026B 0.00
Oragenics (OGEN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Vical (VICL) United States $0.019B 0.00
Histogenics (HSGX) United States $0.019B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Motif Bio Plc (MTFB) United States $0.012B 0.00
Novogen (KZIA) Australia $0.011B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
AmpliPhi Biosciences (ARMP) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Neuralstem (CUR) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.004B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00